HUMAN-LEUKOCYTE INTERFERON-ALPHA VERSUS PODOPHYLLOTOXIN IN CREAM FOR THE TREATMENT OF GENITAL WARTS IN MALES - A PLACEBO-CONTROLLED, DOUBLE-BLIND, COMPARATIVE-STUDY
Ta. Syed et al., HUMAN-LEUKOCYTE INTERFERON-ALPHA VERSUS PODOPHYLLOTOXIN IN CREAM FOR THE TREATMENT OF GENITAL WARTS IN MALES - A PLACEBO-CONTROLLED, DOUBLE-BLIND, COMPARATIVE-STUDY, Dermatology, 191(2), 1995, pp. 129-132
Background: The incidence of overt genital warts, a common sexually tr
ansmitted disease of high prevalence, has been on the rise for the las
t few years. The infection is caused by several types of human papillo
maviruses (HPVs), some of which have been accepted as a factor in the
pathogenesis of genital squamous-cell carcinomas. Objective: The aim o
f this double-blind, placebo-controlled study was to compare and evide
nce differences in clinical efficacy and tolerance between human leuko
cyte interferon-alpha (2x10(6) IU/g) and podophyllotoxin (0.5%), incor
porated in a hydrophilic cream base to cure genital warts in Asian mal
es. Methods: Sixty patients, circumcised, who ranged in age from 18 to
40 years (mean 25.0), diagnosed with the evidence of penoscopy and HP
V DNA (Southern dot blot) as harboring 396 lesions (mean 6.6), were ra
ndomized to three parallel groups. Each subject was allocated a preced
ed tube (40 g) containing one of two trial preparations or matching pl
acebo for 3 days' (consecutive) usage, thrice daily. The study lasted
16 weeks with 4 weeks of active treatment. The patients were examined
on a weekly basis, and a clinically and HPV-DNA-confirmed total regres
sion of lesions was recorded as cured. Patients cured during the treat
ment were spared further therapy and were requested to visit us as sch
eduled for poststudy follow-up. Results: Findings indicated that patie
nts treated with leukocyte interferon-alpha cream had shown comparativ
ely better results than the podophyllotoxin-treated group (90 vs. 55%,
p < 0.0285) or the placebo group (15%). Mild and transient localized
erythema (8.3%), burning sensation (6.6%) and transitory increase in b
ody temperature (> 38 degrees C; 6.6%) were the most frequent adverse
symptoms with no dropout. The study was followed up for 1 year, and ou
t of 32/60 (53.3%) cured patients 3 had a relapse after 10 months. Con
clusion: Leukocyte interferon-alpha (2x10(6) IU/g) has shown comparati
vely better results than 0.5% podophyllotoxin and placebo in a hydroph
ilic cream base, thus leukocyte interferon-alpha in cream may provide
an alternative and effective regimen to treat genital warts in males.